NORML Responds To National Academy of Sciences’ Marijuana Report

mmj

DISTRICT OF COLUMBIA: The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under Read the full article…

How Rescheduling Could Have Changed Cannabis Marketing

DEA needs to step back on mmj

By Celeste Miranda COLORADO: The DEA schedules substances, chemicals and drugs into 5 classified categories. Between Schedule 1 to 5 the level of potential for abuse gets more likely as the number goes down, so Schedule 1 is listed as the most dangerous for the public and Schedule 5 the least.  A Schedule 1 drug has Read the full article…